Another possible marker for CTC isolation/characterization is prostate stem cell antigen (PSCA), a glycosylphosphatidylinositol (GPI)-linked cell-surface protein that is expressed in >80% of PCa patients [20]. Here, PSCA is linked to posterior cortical atrophy.